Brookfield Reaffirms Its Interest in Grifols, Requests More Time for Analysis, Sources Say
LONDON – Brookfield (NYSE: BN), a Canadian fund, reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols (NASDAQ: […]
Healthcare
NASDAQ: GRFS
Grifols (NASDAQ: GRFS) to Allocate $402 Million for New Industrial Centre: Report
Grifols (NASDAQ: GRFS), the Spanish drugmaker, plans to invest 360 million euros ($401.98 million) to build a new industrial plant
Grifols (NASDAQ: GRFS) to Allocate $402 Million for New Industrial Centre: Report Read More »
Grifols (NASDAQ: GRFS) Minority Shareholders Unite to Seek Board Representation
MADRID – Three investment funds with holdings in Spanish drugmaker Grifols (NASDAQ: GRFS) have teamed up to ask to fill
Grifols (NASDAQ: GRFS) Minority Shareholders Unite to Seek Board Representation Read More »
Brookfield in Negotiations with Banks to Fund Grifols Acquisition, Sources Say
BARCELONA/LONDON – Canadian fund Brookfield (NYSE: BAM) is in talks with banks to raise funds for its possible takeover bid
Brookfield in Negotiations with Banks to Fund Grifols Acquisition, Sources Say Read More »
Grifols (NASDAQ: GRFS) Adjusts Financials, Reflects $494 Million Loss on Chinese Investment
MADRID – Spanish pharmaceutical company Grifols (NASDAQ: GRFS) said on Tuesday it had written down its 2020-2023 financial records by
Grifols (NASDAQ: GRFS) Eyes Delisting in Joint Bid from Family and Brookfield
LONDON/MADRID/BARCELONA – The Grifols family and Canadian fund Brookfield have agreed to evaluate a possible joint takeover bid for beleaguered
Grifols (NASDAQ: GRFS) Eyes Delisting in Joint Bid from Family and Brookfield Read More »
Grifols Family and Brookfield Mulling $6 Billion Bid for Grifols (NASDAQ: GRFS)
MADRID – The Grifols family and Canadian fund Brookfield (NYSE: BAM) are in talks to launch a takeover bid for
Grifols Family and Brookfield Mulling $6 Billion Bid for Grifols (NASDAQ: GRFS) Read More »
Grifols (NASDAQ: GRFS) Appoints New Finance Chief Amid Corporate Shake-Up
Spanish drugmaker Grifols (NASDAQ: GRFS) has appointed Rahul Srinivasan as chief financial officer, the company said on Thursday, as the
Grifols (NASDAQ: GRFS) Appoints New Finance Chief Amid Corporate Shake-Up Read More »
Unit of Grifols Shareholder Scranton Reaches Debt Refinancing Deal
LONDON/MADRID – Scranton Enterprises, an entity tied to the Grifols (NASDAQ: GRFS) family, said on Tuesday it reached an agreement
Unit of Grifols Shareholder Scranton Reaches Debt Refinancing Deal Read More »